About us
We aspire to be the premier research-intensive biopharmaceutical company.
Our purpose: We use the power of leading-edge science to save and improve lives around the world
For more than 130 years, we have brought hope to humanity through the discovery and development of important medicines and vaccines.
We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
The first Swiss subsidiary was founded in Zurich in 1963. Today, around 1000 employees from 56 nations work at our locations in the canton of Lucerne and Zurich.
The heart of our mission
Operating responsibly is fundamental to our long-term success, to our obligation to society and to the health and wellbeing of patients and our employees.
Working at MSD
In 2022, MSD was awarded Top Employer Switzerland for the 10th consecutive time.
The team that guides our work
Our leaders focus on our mission to save and improve patients’ lives. This is the foundation of everything we do.
Our values
Our values represent the very core of our character. They guide every decision and action we take.
Our sites
In Lucerne and in our newly opened hub in Zurich we bring creative minds together to transform world class science into life changing medicines and vaccines.
MSD Switzerland by the numbers
Employees
Proportion of woman
Sites in Switzerland
Our areas of focus
Oncology
Our mission is to deliver innovations that extend and improve the lives of people with cancer.
Vaccines
Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.
Infectious diseases
We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV, CMV and antimicrobial therapies.
COVID-19
As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19.
Diabetes
We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.
Immunology
We continue to helping find solutions to auto-immune diseases that affect people across all ages.
CH-NON-00617, 04/2022